日本停用莫德納新冠疫苗

Japan will halt the use of 1.63 million doses of Moderna's Covid-19 vaccine after reports of foreign substances in several lots, drugmaker Takeda and the health ministry said on Thursday.

日本厚生勞動省和武田制藥8月25日表示，國內(nèi)幾個疫苗接種中心報告稱在莫德納新冠疫苗瓶中發(fā)現(xiàn)異物，因此決定暫停使用超過163萬劑的該款疫苗。

Takeda, which is in charge of sales and distribution of the Moderna shot in Japan, said it had informed Moderna and "requested an urgent investigation". Takeda did not detail the nature of the contamination, but said it had not so far received any reports of health concerns arising from affected doses.

武田制藥已要求美國莫德納公司對此事進行緊急調(diào)查。負責莫德納新冠疫苗在日本分銷的武田制藥沒有詳細說明異物的性質(zhì)，但表示目前尚未收到任何該款受影響疫苗引起健康問題的報告。

The health ministry said it would work with Takeda to secure alternative doses to avoid disruption to the country's vaccine program.

日本厚生勞動省表示，將與武田制藥合作，確保替代疫苗的供應，以避免日本疫苗接種進程中斷。

Around 43% of Japan's population is currently fully vaccinated, but the country is battling a record surge of virus cases driven by the more contagious Delta variant.

目前，日本約43%的人口已經(jīng)完成了新冠疫苗接種，但日本正在抗擊由更具傳染性的德爾塔毒株引發(fā)的創(chuàng)紀錄的病例激增。